Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified relaxin B chain peptides and their therapeutic use

Modified relaxin B chain peptides and their therapeutic use

US Patent 10988524 · Granted Apr 27, 2021

Estimated economic value: $33,097,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

PCSK9 antagonist compounds2025
HAM15-52 analogues with improved amylin receptor (hAMY3R) potency2024
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammator2024
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammator2024
Cyclic polypeptides for PCSK9 inhibition2024
Cyclic polypeptides for PCSK9 inhibition2024
Cyclic polypeptides for PCSK9 inhibition2024
Cyclic polypeptides for PCSK9 inhibition2024
Cyclic polypeptides for PCSK9 inhibition2024
Antibody peptide conjugates that have agonist activity at both the glucagon and 2023
Modified lipidated relaxin B chain peptides and their therapeutic use2023
Modified lipidated relaxin B chain peptides and their therapeutic use2023